| NMR Experiment |
|---|
| Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
|---|
| 1 | 2D 1H-1H NOESY | 1 mM DNA (5'-D(*AP*AP*CP*AP*AP*TP*TP*GP*TP*T)-3')-1, 1 mM Pyrrolo[2,1-c][1,4]benzodiazepine-Benzimidazole Hybrid-2, 100 mM NaCl-3, 20 mM PO4-4 | 100% D2O | 0.28 | 7 | ambient | 295 | |
| 2 | 2D DQF-COSY | 1 mM DNA (5'-D(*AP*AP*CP*AP*AP*TP*TP*GP*TP*T)-3')-1, 1 mM Pyrrolo[2,1-c][1,4]benzodiazepine-Benzimidazole Hybrid-2, 100 mM NaCl-3, 20 mM PO4-4 | 100% D2O | 0.28 | 7 | ambient | 295 | |
| 3 | 2D 1H-1H TOCSY | 1 mM DNA (5'-D(*AP*AP*CP*AP*AP*TP*TP*GP*TP*T)-3')-1, 1 mM Pyrrolo[2,1-c][1,4]benzodiazepine-Benzimidazole Hybrid-2, 100 mM NaCl-3, 20 mM PO4-4 | 100% D2O | 0.28 | 7 | ambient | 295 | |
| 4 | 2D 1H-1H NOESY | 1 mM DNA (5'-D(*AP*AP*CP*AP*AP*TP*TP*GP*TP*T)-3')-5, 1 mM Pyrrolo[2,1-c][1,4]benzodiazepine-Benzimidazole Hybrid-6, 100 mM NaCl-7, 20 mM PO4-8 | 90% H2O/10% D2O | 0.28 | 7 | ambient | 283 | |